EI
BIO icon

Ellevest Inc’s Bio-Rad Laboratories Class A BIO Stock Holding History

Ellevest Inc’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-25
Closed -$12K – 519
2023
Q1 		$12K Sell
25
-3
-11% -$1.4K ﹤0.01% 992
2022
Q4 		$11.8K Sell
28
-188
-87% -$75.9K ﹤0.01% 990
2022
Q3 		$90K Buy
216
+168
+350% +$83.8K 0.01% 439
2022
Q2 		$24K Buy
+48
New +$25K ﹤0.01% 721
2020
Q4 		– Sell
-48
Closed -$25K – 1195
2020
Q3 		$25K Sell
48
-12
-20% -$6.08K ﹤0.01% 483
2020
Q2 		$27K Sell
60
-20
-25% -$8.83K 0.01% 444
2020
Q1 		$28K Buy
80
+6
+8% +$2.21K 0.01% 361
2019
Q4 		$27K Buy
+74
New +$26.1K 0.01% 354

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return